215 related articles for article (PubMed ID: 28362259)
1. Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate.
Juul M; Bertl J; Guo Q; Nielsen MM; Świtnicki M; Hornshøj H; Madsen T; Hobolth A; Pedersen JS
Elife; 2017 Mar; 6():. PubMed ID: 28362259
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer screen for mutations in non-coding elements with conservation and cancer specificity reveals correlations with expression and survival.
Hornshøj H; Nielsen MM; Sinnott-Armstrong NA; Świtnicki MP; Juul M; Madsen T; Sallari R; Kellis M; Ørntoft T; Hobolth A; Pedersen JS
NPJ Genom Med; 2018; 3():1. PubMed ID: 29354286
[TBL] [Abstract][Full Text] [Related]
3. Identification of coding and non-coding mutational hotspots in cancer genomes.
Piraino SW; Furney SJ
BMC Genomics; 2017 Jan; 18(1):17. PubMed ID: 28056774
[TBL] [Abstract][Full Text] [Related]
4. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
5. Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions.
Wong JKL; Aichmüller C; Schulze M; Hlevnjak M; Elgaafary S; Lichter P; Zapatka M
Nat Commun; 2022 Jan; 13(1):178. PubMed ID: 35013316
[TBL] [Abstract][Full Text] [Related]
6. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
Narayan S; Bader GD; Reimand J
Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
[TBL] [Abstract][Full Text] [Related]
7. Comparison of different functional prediction scores using a gene-based permutation model for identifying cancer driver genes.
Nono AD; Chen K; Liu X
BMC Med Genomics; 2019 Jan; 12(Suppl 1):22. PubMed ID: 30704472
[TBL] [Abstract][Full Text] [Related]
8. A site specific model and analysis of the neutral somatic mutation rate in whole-genome cancer data.
Bertl J; Guo Q; Juul M; Besenbacher S; Nielsen MM; Hornshøj H; Pedersen JS; Hobolth A
BMC Bioinformatics; 2018 Apr; 19(1):147. PubMed ID: 29673314
[TBL] [Abstract][Full Text] [Related]
9. Combined burden and functional impact tests for cancer driver discovery using DriverPower.
Shuai S; ; Gallinger S; Stein LD;
Nat Commun; 2020 Feb; 11(1):734. PubMed ID: 32024818
[TBL] [Abstract][Full Text] [Related]
10. Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks.
Zhu H; Uusküla-Reimand L; Isaev K; Wadi L; Alizada A; Shuai S; Huang V; Aduluso-Nwaobasi D; Paczkowska M; Abd-Rabbo D; Ocsenas O; Liang M; Thompson JD; Li Y; Ruan L; Krassowski M; Dzneladze I; Simpson JT; Lupien M; Stein LD; Boutros PC; Wilson MD; Reimand J
Mol Cell; 2020 Mar; 77(6):1307-1321.e10. PubMed ID: 31954095
[TBL] [Abstract][Full Text] [Related]
11. ncdDetect2: improved models of the site-specific mutation rate in cancer and driver detection with robust significance evaluation.
Juul M; Madsen T; Guo Q; Bertl J; Hobolth A; Kellis M; Pedersen JS
Bioinformatics; 2019 Jan; 35(2):189-199. PubMed ID: 29945188
[TBL] [Abstract][Full Text] [Related]
12. Identification of High-Impact cis-Regulatory Mutations Using Transcription Factor Specific Random Forest Models.
Svetlichnyy D; Imrichova H; Fiers M; Kalender Atak Z; Aerts S
PLoS Comput Biol; 2015 Nov; 11(11):e1004590. PubMed ID: 26562774
[TBL] [Abstract][Full Text] [Related]
13. Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events.
Ashouri A; Sayin VI; Van den Eynden J; Singh SX; Papagiannakopoulos T; Larsson E
Nat Commun; 2016 Oct; 7():13197. PubMed ID: 28959951
[TBL] [Abstract][Full Text] [Related]
14. Mutational landscape of RNA-binding proteins in human cancers.
Neelamraju Y; Gonzalez-Perez A; Bhat-Nakshatri P; Nakshatri H; Janga SC
RNA Biol; 2018 Jan; 15(1):115-129. PubMed ID: 29023197
[TBL] [Abstract][Full Text] [Related]
15. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.
Rheinbay E; Nielsen MM; Abascal F; Wala JA; Shapira O; Tiao G; Hornshøj H; Hess JM; Juul RI; Lin Z; Feuerbach L; Sabarinathan R; Madsen T; Kim J; Mularoni L; Shuai S; Lanzós A; Herrmann C; Maruvka YE; Shen C; Amin SB; Bandopadhayay P; Bertl J; Boroevich KA; Busanovich J; Carlevaro-Fita J; Chakravarty D; Chan CWY; Craft D; Dhingra P; Diamanti K; Fonseca NA; Gonzalez-Perez A; Guo Q; Hamilton MP; Haradhvala NJ; Hong C; Isaev K; Johnson TA; Juul M; Kahles A; Kahraman A; Kim Y; Komorowski J; Kumar K; Kumar S; Lee D; Lehmann KV; Li Y; Liu EM; Lochovsky L; Park K; Pich O; Roberts ND; Saksena G; Schumacher SE; Sidiropoulos N; Sieverling L; Sinnott-Armstrong N; Stewart C; Tamborero D; Tubio JMC; Umer HM; Uusküla-Reimand L; Wadelius C; Wadi L; Yao X; Zhang CZ; Zhang J; Haber JE; Hobolth A; Imielinski M; Kellis M; Lawrence MS; von Mering C; Nakagawa H; Raphael BJ; Rubin MA; Sander C; Stein LD; Stuart JM; Tsunoda T; Wheeler DA; Johnson R; Reimand J; Gerstein M; Khurana E; Campbell PJ; López-Bigas N; ; ; Weischenfeldt J; Beroukhim R; Martincorena I; Pedersen JS; Getz G;
Nature; 2020 Feb; 578(7793):102-111. PubMed ID: 32025015
[TBL] [Abstract][Full Text] [Related]
16. The landscape and driver potential of site-specific hotspots across cancer genomes.
Juul RI; Nielsen MM; Juul M; Feuerbach L; Pedersen JS
NPJ Genom Med; 2021 May; 6(1):33. PubMed ID: 33986299
[TBL] [Abstract][Full Text] [Related]
17. OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations.
Mularoni L; Sabarinathan R; Deu-Pons J; Gonzalez-Perez A; López-Bigas N
Genome Biol; 2016 Jun; 17(1):128. PubMed ID: 27311963
[TBL] [Abstract][Full Text] [Related]
18. SigsPack, a package for cancer mutational signatures.
Schumann F; Blanc E; Messerschmidt C; Blankenstein T; Busse A; Beule D
BMC Bioinformatics; 2019 Sep; 20(1):450. PubMed ID: 31477009
[TBL] [Abstract][Full Text] [Related]
19. Incorporating mutational heterogeneity to identify genes that are enriched for synonymous mutations in cancer.
Rao Y; Ahmed N; Pritchard J; O'Brien EP
BMC Bioinformatics; 2023 Dec; 24(1):462. PubMed ID: 38062391
[TBL] [Abstract][Full Text] [Related]
20. Mining the coding and non-coding genome for cancer drivers.
Li J; Drubay D; Michiels S; Gautheret D
Cancer Lett; 2015 Dec; 369(2):307-15. PubMed ID: 26433158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]